INTRODUCTION
Five to ten percent of zinc finger proteins contain at their N-terminus a conserved 120 amino acid motif called the BTB/POZ-domain (for Broad-Complex, Tramtrack, and Bric-a-brac/Pox virus and zinc finger), from hereon referred to as the POZ-domain.
This domain is also found in some actin binding proteins, ion channels, and other proteins of various functions (1) (2) (3) , recently reviewed in (4) The known POZ-domain protein DNA binding sites display considerable sequence heterogeneity. Two POZ-domain zinc finger proteins whose DNA binding properties have been characterized in some detail, i.e. the GAGA factor and Kaiso, bind DNA with surprising flexibility (6) (7) (8) . The GAGA factor can bind variable numbers of sites with flexible spacing, and Kaiso recognizes distinct binding sites of different sequences. It is not known whether this flexibility is a frequent feature of POZ-domain proteins, but at least in these cases it is consistent with these proteins playing a role in the regulation of a variety of genes.
We have previously described FBI-1 (Factor Binding to IST) (9) , a human protein that binds specifically to an unusual human immunodeficiency virus type 1 (HIV-1) promoter element, the inducer of short transcripts (IST) (10, 11) . Molecular cloning revealed FBI-1 to be a 61.5 kDa Krüppel-type zinc finger protein with a POZdomain at the N-terminus and four C 2-H 2 zinc fingers at the C-terminus (12) . FBI-1 can self-associate via both the POZ and zinc finger domains (12) . In addition, it associates via its POZ-domain with activation competent, but not with activation deficient, HIV-1 Tat protein (13) . Indeed, over-expressed FBI-1 stimulates Tat transactivation in transient transfection assays and partially co-localizes with Tat and the cellular Tat co-factor P-TEFb in the splicing factor-rich nuclear speckles (13) .
Consistent with playing a role in cellular transcription regulation, a less soluble fraction of FBI-1 also localizes to an unusual subnuclear domain where it appears to associate with active chromatin (13) . Indeed, FBI-1 has been shown to repress transcription of some extracellular matrix genes (14) (these authors refer to FBI-1 as hcKrox-β) and of the ADH5/FDH promoter (15) . In the latter case, the proposed mechanism of repression is interference by FBI-1 with the binding of SP-1 to a GC-box adjacent to an FBI-1 binding site. Most recently, FBI-1 was identified as one of several genes over-expressed in precursor B-leukemia cells protected from apoptosis by integrin stimulation (16) .
Two mammalian homologues of FBI-1, whose DNA binding sites are unknown, have been isolated. The mouse homologue, Leukemia/Lymphoma Related Factor (LRF), is a developmentally highly regulated nuclear protein that associates with the POZdomain protein BCL-6 (17). The rat homologue, Osteoclast-Derived Zinc Finger Protein (OCZF), has been shown to play a role in osteoclast differentiation (18) .
Together, these observations suggest that FBI-1 is a transcription factor involved in diverse aspects of development and differentiation.
Considering the paucity of information on DNA binding of POZ-domain proteins, we have used the binding site of FBI-1 in the HIV-1 promoter as well as other viral and cellular FBI-1 binding sites of unknown function to characterize the DNA binding properties of a POZ-domain protein in detail. We find that high-affinity FBI-1 binding sites consist of either a single guanine-rich site or two half-sites each with the consensus sequence G-A / G -G-G-G-T / C -C / T -T / C -C / T , whose relative orientation and spacing vary greatly. Taken together, our results demonstrate that FBI-1 binds DNA with remarkable flexibility. Consistent with it playing a role in diverse biological processes, FBI-1 thus has the potential to act at a variety of cellular sequences.
EXPERIMENTAL PROCEDURES
Plasmids. Relevant sequences of all constructs are shown in Fig. 1 and 5A . The constructs DD, DD∆30, UD and UD∆25 were generated as follows. Oligonucleotides with complementary sequences of approximately 30 nucleotides at their 3' ends were annealed and the 3' recesses then filled in with the large fragment of DNA polymerase 1 (Klenow Fragment). The resulting double-stranded DNA fragments carried the desired sequence changes as well as BamH I restriction sites at both ends. After digestion with BamH I, the fragments were ligated into pUC119 cleaved with BamH I. These constructs carry the following sequence changes: In DD and DD∆30, the HIV-1 sequence segment from +49 to +84 is everted. In addition, in DD∆30 the segment from +15 to +44 is deleted. In UD and UD∆25, the segments comprising -22 to +12 and +49 to +84 are everted. In addition, in UD∆25 the sequence from +19 to +43 is deleted.
pHIV-1/RpUC119 was constructed by ligating the Pvu II/BamH I fragment from pHIV-1/R containing HIV-1 sequences -19 to +82 into pUC119 cleaved with Hinc II and BamH I. 3'pIST/pUC was constructed by ligating the Bgl II/BamH I fragment from pIST, containing HIV-1 sequences +21 to +82, into pUC119 cleaved with BamH I.
5'IST/pUC was generated by ligating the Pvu II/Bgl II fragment from pHIV-1/R, comprising HIV-1 sequences -19 to +24, into pUC119 cleaved with BamH I and Hinc II. These constructs allowed for the amplification of probe fragments containing the respective HIV-1 sequences with universal primers hybridizing on either side of the pUC119 polylinker. 5∆2/R was constructed by oligonucleotide-mediated site-directed mutagenesis (19) .
The deletion mutants D1 through D8 were constructed by ligating doublestranded oligonucleotides carrying the appropriate deletions into the vector pHIV-1/R cleaved with Xho I andAfl II. The latter, as well as plasmids pIST and pIST/BU-, are described in (11) . WT [ABC] WT is identical to WT [WT] WT described in (11) , except that the insert between positions +24 and +40 corresponds to the +1 to +59 fragment from msABC (3).
Electrophoretic mobility shift assays. Electrophoretic mobility shift assays (EMSA) were performed with end-labeled DNA probes generated by PCR amplification as described previously (9) . The use of a common radiolabeled PCR primer assured equal specific activity of all probes. The sources of FBI-1 were either heparin sepharose or hydroxy apatite column fractions from HeLa cell nuclear extract (9) . In Fig. 4C , two µl of heparin sepharose column fraction (20-fold purified in FBI-1 binding activity as compared to the nuclear extract, containing 3.5 µg/µl total protein and 5 ng/µl FBI-1 protein (9,20)) were used per binding reaction. In all other experiments, 0.5 to 1 µl of hydroxy apatite column fraction (54-fold purified in FBI-1 binding activity, containing 3.9 µg/µl total protein and 15 ng/µl FBI-1 protein (9,20)) was used per binding reaction.
FBI-1 contained in nuclear extract or the column fractions of different degrees of purification binds to DNA in the same sequence-specific manner (9) .
Methylation interference assays. Methylation interference assays with dimethylsulfate (DMS) were carried out essentially as described in (21). DNA-protein binding reactions were identical to those employed for EMSAs (see above), except that they contained 300 000 cpm of end-labeled probe and 2-3 µl of hydroxy apatite column fraction containing partially purified FBI-1 (9) in a total volume of 50 µl. After electrophoretic separation of bound from unbound DNA, 100,000 cpm were typically detected in the band corresponding to the FBI-1/DNA complex.
RESULTS
FBI-1 recognizes an unusually large bipartite binding site in the HIV-1 promoter, which is depicted in Fig. 1A . It spans approximately 100 base pairs between positions -23 and +78 with respect to the transcription start site and includes the IST promoter element (9) . This binding site is composed of two separate "half-sites": the 5' half-site, which is the most important for binding, consists of specific sequences from position +1 to +8 as well as non-specific sequences from position -22 to -1. The 3' half-site, which is less important but nevertheless contributes to efficient binding, consists of sequences from position +49 to +78, with the sequences from +56 to +66 contributing most to the affinity of this half-site. The 5' and 3' half-sites are largely contained within the previously described IST 5' and 3' functional half-elements (11) . We characterized the interaction of FBI-1 with the HIV-1 promoter in detail by testing a number of mutations, which are depicted in Fig. 1B . We also used the methylation interference assay to identify guanine residues in close proximity to FBI-1 in the HIV-1 promoter, several cellular promoters, and the Ad2 major late promoter. half-site was also a better competitor than the 3' half-site (Fig. 2B ).
The binding of FBI-1 to an isolated 3' half-site was unexpected, because we previously observed that FBI-1 did not bind detectably to a mutant probe [msABC(5')] carrying an intact 3' FBI-1 half-site and a mutated 5' half-site (9) . This discrepancy probably results from the higher concentration of nonspecific competitor nucleic acids used in our previous experiments. In addition, it is possible that the mutated 5' half-site, which is not present in the probes used here ( Thus, D6, which lacked the sequences from +8 to +52, bound FBI-1 with wild-type efficiency. In contrast, the next deletion, D7, which lacked sequences from +6 to +55, abolished detectable binding (compare lanes 3, 10, and 11), either because it removed sequences required for binding or because it gave rise to a suboptimal spacing between the half sites. The D6 mutant thus localizes the maximal extent of the "inward" borders of the 5' and 3' half-sites more precisely: +7 for the 3' border of the 5' half-site, and +53 for the 5' border of the 3' half-site. As described below ( Fig. 5A and 6A) , methylation of the G residue at position +7 interfered with binding of FBI-1, thus localizing the 3' border of the 5' half-site at +7. Moreover, our previous analysis of clustered point mutations mapped the 5' border of the 3' half site between +49 and +56 (see bracket on top on Fig. 4A) . Thus, we can now localize the 5' border of the 3' half site between +53 and +56. These new maximal "inward" borders of the 5' and 3' halfsites are indicated below the sequences in Fig. 4A . the size of the wedges correlates with the degree of interference). On the lower strand, methylation of two guanine residues at +5 and +7, as well as three guanine residues at +57, +58, +59 interfered the most with FBI-1 binding, with less significant interference also observed at positions +61, +71 and +73 (compare lanes 3 and 4). Together with the deletion analysis described above (Fig. 4B) , the observation that methylation of guanine +7 interferes strongly with binding suggests that the 3' border of the 5' half-site is at this position (see Fig. 4A ).
In summary, the methylation interference assay identified two clusters of guanine residues whose chemical modification within the major groove of the DNA interfered severely with FBI-1 binding: one located between +1 and +7, and one located between +57 and +59 (see bottom panel of Fig. 6A ). These two clusters reside within the two regions in the HIV-1 promoter that were identified previously by EMSA as contributing most to FBI-1 binding (9) (see also Fig. 1A) . In the Ad2 MLP, methylation of three clusters of G residues flanking the TATA box interfered severely with binding, revealing a curious guanine-rich binding site, where the 5' cluster and the most 3' cluster are followed by a cytosine and resemble a pair of direct repeats (Fig. 5B) . In the first intron of the c-fos gene, the FBI-1 binding site consisted of two direct repeats (Fig. 5C ). In the c-myc P1 promoter, we identified an FBI-1 binding site consisting of two inverted repeats reminiscent of the site in the HIV-1 promoter, except that the distance between the half-sites was significantly shorter (Fig.   5D ). Moreover, in the c-myc P2 promoter, we found a binding site consisting of a single half-site, and in the first exon of the c-fos gene, a site consisting of two abutting everted repeats (data not shown but summarized in Fig. 6A ). The number of guanines whose methylation interfered with binding varied from 5 (c-myc P2) to 17 (MLP), and the distance between the half-sites (calculated between the first of the three strictly conserved guanines identified in the consensus sequences in Fig. 6B ) varied between 7 (c-fos, exon 1) and 51 bp (c-fos, intron 1).
This analysis revealed no correlation between the affinity for FBI-1 and the distance between the half-sites or the orientation of the half-sites with respect to each other. Moreover, as exemplified by the c-myc P2 promoter binding site, a single site was sufficient for binding. These results agree well with the above observations that each HIV-1 half-site can bind FBI-1 on its own (see Fig. 2 ) and that the relative orientation and spacing of the HIV-1 half-sites can be varied (see Fig. 4B and 4C) . Thus, even though the functional significance of FBI-1 binding to these sites is unknown, these findings provide further evidence that FBI-1 binds DNA with remarkable flexibility. to +78 (9) . The deletion analysis and methylation interference assay described here, together with our previous analysis of cluster point mutations (9) , allow us to localize the inward borders of the FBI-1 half-sites more accurately to +7 (3' border of the 5' halfsite) and between +53 and +56 (5' border of the 3' half-site). Remarkably, these borders are close to or coincide with the ends of the imperfect repeats present in each half-site.
Outside of the imperfect repeats, however, the two half-sites display considerable sequence dissimilarity. Indeed, the sequences forming the upper part of the 3' half-site (5' of the guanine triplet on the lower strand, i.e. positions +78 to +60), contribute to FBI-1 binding in a sequence-specific manner, whereas FBI-1 makes no sequencespecific contacts in the corresponding segment of the 5' half-site (5' of the guanine triplet on the upper strand, i.e. positions -22 to -1) (9). The observation that mutating the 3' repeat to render it identical to the 5' repeat increases the affinity of the probes for FBI-1 suggests, however, that both half-sites are recognized by identical DNA binding domains.
What is the stoichiometry of FBI-1 on DNA? Probes carrying mutations in one half-site form FBI-1/DNA complexes of the same electrophoretic mobilities as wildtype probes of the same length (9) . Moreover, the FBI-1/DNA complexes that form on probes carrying a single binding site migrate only slightly faster than those formed on full-length probes carrying two half-sites (see Fig. 2A (18) . Consistent with these similarities, the rat homologue of FBI-1, OCZF, binds to both the c-Krox tandem site and the Egr-1 single site, albeit with weaker affinity than their cognate proteins (18) . Moreover, at least two other POZ-domain zinc finger protein interact with DNA in a flexible manner: the Kaiso protein recognizes the specific consensus sequence TCCTGCNA as well as methyl-CpG dinucleotides (8) , and the GAGA factor binds co-operatively to repeats of the sequence motif GAGA that can vary in number and spacing (6, 7) . The asterisks indicate that the lower strand is shown. All sequences are shown 5' to 3'.
In the consensus sequence, residues in bold appear at least in six out of the eleven binding sites aligned.
